Literature DB >> 9761390

Life expectancy in British Marfan syndrome populations.

J R Gray1, A B Bridges, R R West, L McLeish, A G Stuart, J C Dean, M E Porteous, M Boxer, S J Davies.   

Abstract

A total of 206 patients with Marfan syndrome were ascertained throughout genetic clinics in Wales and Scotland during the period 1970-1990. There were 45 deaths representing 22% of the cohort. Mean age at death was 45.3+/-16.5 years. 50% median cumulative survival in the total cohort (n=206) was 53 years for males and 72 years for females. Multivariate analysis confirmed severity as the best independent indicator of survival. These findings and survival curves will assist in the counselling of British families and individuals with Marfan syndrome.

Entities:  

Mesh:

Year:  1998        PMID: 9761390     DOI: 10.1111/j.1399-0004.1998.tb03714.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  16 in total

Review 1.  Management of Marfan syndrome.

Authors:  John C S Dean
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

2.  Coexistence of anomalous origin of the coronary arteries and severe aortic regurgitation in Marfan syndrome.

Authors:  Dimitris P Papadopoulos; Ioannis Moyssakis; Vassilios E Votteas
Journal:  Clin Rheumatol       Date:  2005-11-03       Impact factor: 2.980

3.  Natural history of cardiovascular manifestations in Marfan syndrome.

Authors:  C D van Karnebeek; M S Naeff; B J Mulder; R C Hennekam; M Offringa
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

4.  Cardiovascular management of marfan syndrome in the young.

Authors:  Angela M Sharkey
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-09

5.  Recurrent and founder mutations in the Netherlands: Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation.

Authors:  J J J Aalberts; A G Schuurman; G Pals; B J C Hamel; G Bosman; Y Hilhorst-Hofstee; D Q C M Barge-Schaapveld; B J M Mulder; M P van den Berg; J P van Tintelen
Journal:  Neth Heart J       Date:  2010-02       Impact factor: 2.380

Review 6.  Large ascending aortic aneurysm and severe aortic regurgitation in a 7-year-old child with Marfan syndrome and a review of the literature. Marfan syndrome in childhood.

Authors:  Mehmet Yazici; Serdar Soydinç; Vedat Davutoğlu; Ilyas Akdemir; M Hakan Dinçkal
Journal:  Int J Cardiovasc Imaging       Date:  2004-08       Impact factor: 2.357

7.  Age and sex dependency of thoracic aortopathy in a mouse model of Marfan syndrome.

Authors:  Nazli Gharraee; Yujian Sun; Joseph A Swisher; Susan M Lessner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-10-29       Impact factor: 4.733

8.  Prevalence data on all Ghent features in a cross-sectional study of 87 adults with proven Marfan syndrome.

Authors:  Svend Rand-Hendriksen; Rigmor Lundby; Lena Tjeldhorn; Kai Andersen; Jon Offstad; Svein Ove Semb; Hans-Jørgen Smith; Benedicte Paus; Odd Geiran
Journal:  Eur J Hum Genet       Date:  2009-03-18       Impact factor: 4.246

9.  Thrombolysis in a stroke patient with Marfan syndrome.

Authors:  J Chembala; I Natarajan; C Roffe
Journal:  JRSM Short Rep       Date:  2012-04-10

10.  Disease-specific Growth Charts of Marfan Syndrome Patients in Korea.

Authors:  Younghee Kwun; Su Jin Kim; Jieun Lee; Tsuyoshi Isojima; Doo-Seok Choi; Duk-Kyung Kim; June Huh; I-Seok Kang; MiSun Chang; Sung Yoon Cho; Young Bae Sohn; Sung Won Park; Dong-Kyu Jin
Journal:  J Korean Med Sci       Date:  2015-06-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.